337 related articles for article (PubMed ID: 16750840)
1. Steroid receptor profiling of vinclozolin and its primary metabolites.
Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
[TBL] [Abstract][Full Text] [Related]
2. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
Wilson VS; Bobseine K; Lambright CR; Gray LE
Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
[TBL] [Abstract][Full Text] [Related]
3. Vinclozolin does not alter progesterone receptor (PR) function in vivo despite inhibition of PR binding by its metabolites in vitro.
Laws SC; Carey SA; Kelce WR; Cooper RL; Gray LE
Toxicology; 1996 Sep; 112(3):173-82. PubMed ID: 8845038
[TBL] [Abstract][Full Text] [Related]
4. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
5. Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening.
Hartig PC; Bobseine KL; Britt BH; Cardon MC; Lambright CR; Wilson VS; Gray LE
Toxicol Sci; 2002 Mar; 66(1):82-90. PubMed ID: 11861975
[TBL] [Abstract][Full Text] [Related]
6. Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites.
Escande A; Servant N; Rabenoelina F; Auzou G; Kloosterboer H; Cavaillès V; Balaguer P; Maudelonde T
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):8-14. PubMed ID: 19464167
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.
Wong C; Kelce WR; Sar M; Wilson EM
J Biol Chem; 1995 Aug; 270(34):19998-20003. PubMed ID: 7650017
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
Kim HJ; Park YI; Dong MS
Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434
[TBL] [Abstract][Full Text] [Related]
9. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites.
Kelce WR; Monosson E; Gamcsik MP; Laws SC; Gray LE
Toxicol Appl Pharmacol; 1994 Jun; 126(2):276-85. PubMed ID: 8209380
[TBL] [Abstract][Full Text] [Related]
10. The establishment of the long terminal repeat of the mouse mammary tumor virus into CV-1 cells allows a functional analysis of steroid receptors.
Couette B; Le Ricousse S; Fortin D; Rafestin-Oblin ME; Richard-Foy H
Biochim Biophys Acta; 1994 Nov; 1219(3):607-12. PubMed ID: 7948018
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
Fuhrmann U; Slater EP; Fritzemeier KH
Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
[TBL] [Abstract][Full Text] [Related]
13. Intracellular distribution of vinclozolin and its metabolites differently affects 5α-dihydrotestosterone (DHT)-induced PSA secretion in LNCaP cells.
Marcoccia D; Smeriglio A; Mantovani A; Trombetta D; Lorenzetti S
Reprod Toxicol; 2022 Aug; 111():83-91. PubMed ID: 35595151
[TBL] [Abstract][Full Text] [Related]
14. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
15. Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell lines of diclofenac, 4-hydroxydiclofenac and paracetamol.
Klopčič I; Markovič T; Mlinarič-Raščan I; Sollner Dolenc M
Toxicol Lett; 2018 Sep; 294():95-104. PubMed ID: 29777833
[TBL] [Abstract][Full Text] [Related]
16. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
[TBL] [Abstract][Full Text] [Related]
17. Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives.
Schoonen WG; Deckers GH; de Gooijer ME; de Ries R; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2000 Nov; 74(4):213-22. PubMed ID: 11162927
[TBL] [Abstract][Full Text] [Related]
18. Potential endocrine-disrupting effects of metals via interference with glucocorticoid and mineralocorticoid receptors.
Zhang J; Yang Y; Liu W; Liu J
Environ Pollut; 2018 Nov; 242(Pt A):12-18. PubMed ID: 29957541
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities.
Attardi BJ; Page ST; Hild SA; Coss CC; Matsumoto AM
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):151-61. PubMed ID: 19941958
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells.
Jung-Testas I; Renoir M; Bugnard H; Greene GL; Baulieu EE
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):621-31. PubMed ID: 1562533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
